Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

Presentation

Treating Hair Loss in Women with Cancer

Description

The speaker presents insights on treating hair loss in women affected by cancer, specifically focusing on the psychological and physical impacts of chemotherapy-induced alopecia. Many patients express deep concern about hair loss, often perceiving it as their worst side effect of cancer treatment. The speaker emphasizes the importance of pre-chemotherapy consultations, where patients are educated on the hair loss process, potential interventions, and the use of cooling cap devices that may help preserve hair during treatment, though efficacy varies. During chemotherapy, managing scalp health is crucial, and the speaker discusses the use of medications like minoxidil and dietary advice. Post-chemotherapy, most patients can expect hair regrowth within months, often with altered texture. The speaker also notes that while many regimens lead to temporary hair loss, some cases result in permanent damage, advising caution with certain supplements that might interfere with treatment. The overall message stresses that while hair loss is a significant concern, supportive care and proper interventions can help improve patients' quality of life during and after cancer treatments.

View more

Conclusions

Hair loss is a significant concern for cancer patients undergoing chemotherapy, often rated as the worst side effect.
Consultation before chemotherapy is crucial for addressing hair loss concerns and documenting hair status.
Cooling caps show approximately 60% efficacy in reducing hair loss during chemotherapy for some patients, primarily in private settings.
Chemotherapy-induced alopecia can be transient for 90% of patients, with visible hair regrowth expected in 3-6 months after treatment.
Post-chemotherapy, a tailored approach including topical treatments and proper hair care is essential for hair recovery.
Certain dietary and cosmetic practices should be carefully assessed to prevent complications and support hair health after chemotherapy.
Risks of using substances like biotin and formaldehyde should be communicated to patients to avoid adverse effects during and after treatment.
Some patients may experience permanent hair loss, which can be managed with treatments such as topical or oral minoxidil.

Müller Ramos P. et al. Minoxidil 1 mg oral versus minoxidil 5% topical solution for the treatment of female-pattern hair loss: A randomized clinical trial. JAAD 2019.
Tongyu C. Wikramanayake *, Nicole I. Haberland, Aysun Akhundlu, Andrea Laboy Nieves and Mariya Miteva. Prevention and Treatment of Chemotherapy-Induced Alopecia: What Is Available and What Is Coming? Current Oncology.